Tubo, Rosita B.
HRN: 29-41-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/06/2026
08/12/2026
IV
4.5gm
Q8
Infected Wound
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: